News

Rigel has announced that R788 (fostamatinib disodium) produced significant clinical improvement in rheumatoid arthritis (RA) patients. The results were obtained from the recently completed TASKi2 phase 2b clinical

Amylin has announced positive results from a 28-week dose-ranging study of pramlintide/metreleptin, a combination treatment comprising pramlintide and metreleptin in overweight and obese patients. This phase-II study successfully

ICON has acquired Veeda Laboratories, a wholly-owned subsidiary of Veeda Clinical Research Group. The acquisition adds to ICON Development Solutions’ existing bioanalytical and immunoassay capabilities, which are delivered

Resurrection Health Care of Chicago has signed an agreement to implement HealthPort’s RACPro Basic software. A solution for the Recovery Audit Contractor (RAC) initiative, RACPro Basic enables hospitals

Merge Healthcare has released Frontiers 4.2.2, a surgery management solution, to improve hospital workflow by capturing and charting clinical data throughout the entire perioperative-care process.   Frontiers automates

CLC bio has announced that Dutch sequencing service center, BaseClear would provide all customers receiving Next Generation Sequencing data, with a license for CLC Genomics Workbench. It is

Pfizer has reported that it is disappointed by the Canadian Federal Court’s decision declaring its patent covering amlodipine besylate, the active ingredient in Norvasc, as invalid. The company

Sciele has reported the availability of Ulesfia (benzyl alcohol) lotion that kills head lice by asphyxiation, without potential neurotoxic side effects. Approved by the FDA, Ulesfia is indicated

Shanghai ChemPartner (ChemPartner) has expanded its integrated drug discovery research collaboration with Agios. ChemPartner would provide integrated services in the areas of protein science, HTS, in-vitro enzyme assay,